Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Impetigo - Overview
Impetigo - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Impetigo - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Impetigo - Companies Involved in Therapeutics Development
FUJIFILM Toyama Chemical Co Ltd
Laboratories Ojer Pharma SL
Next Science Ltd
Union Therapeutics AS
Vaxcyte Inc
Impetigo - Drug Profiles
Drug for Impetigo - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
mupirocin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
niclosamide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ozenoxacin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Recombint Enzyme to Disrupt Bacterial Cell Wall for Impetigo - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Synthetic Peptides for Infectious Disease - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
VAX-24 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Impetigo - Dormant Projects
Impetigo - Discontinued Products
Impetigo - Product Development Milestones
Featured News & Press Releases
Mar 05, 2018: Newly Approved Treatment for Impetigo to be Commercialized by Cutanea Life Sciences
Jan 08, 2018: Cipher Pharmaceuticals Announces Cadian Launch of OZANEX (ozenoxacin cream 1%), a Novel Topical Antibiotic
Dec 14, 2017: Medimetriks Pharmaceuticals Receives FDA Approval for Xepi (ozenoxacin) Cream, 1%, a Novel Topical Antibiotic for Impetigo
May 08, 2017: Cipher Pharmaceuticals Receives Health Cada Approval of OZANEX (ozenoxacin cream 1%)
Jul 12, 2016: Cipher Pharmaceuticals announces Ozenoxacin accepted for review by Health Cada
Jun 27, 2016: Medimetriks Pharmaceuticals New Drug Application for Ozenoxacin Cream, 1% Accepted for Review by FDA
Jun 27, 2016: Medimetriks Pharmaceuticals Submits a New Drug Application to FDA for Ozenoxacin Cream, 1%, a Novel Impetigo Treatment
Jun 12, 2014: Medimetriks Pharmaceuticals Announces that the Second Phase III Study for Ozenoxacin has been Initiated by Ferrer
Jun 05, 2013: Ferrer Completes Phase III Clinical Trial Of Ozenoxacin In Adult And Pediatric Patients With Impetigo
Oct 05, 2012: Ferrer Successfully Completes Absorption, Tolerability And Safety Study In Juveniles As Young As Two Months Of Age For New Antibacterial Compound Ozenoxacin
Jan 19, 2012: Ferrer Initiates Phase III Clinical Studies For Ozenoxacin In Development As Topical Treatment For Impetigo And Other Infectious Dermatological Conditions
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Impetigo, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020


List of Tables


Number of Products under Development for Impetigo, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Impetigo - Pipeline by FUJIFILM Toyama Chemical Co Ltd, H2 2020
Impetigo - Pipeline by Laboratories Ojer Pharma SL, H2 2020
Impetigo - Pipeline by Next Science Ltd, H2 2020
Impetigo - Pipeline by Union Therapeutics AS, H2 2020
Impetigo - Pipeline by Vaxcyte Inc, H2 2020
Impetigo - Dormant Projects, H2 2020
Impetigo - Discontinued Products, H2 2020